ClinicalTrials.gov
public full text
Public Domain
Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients
To evaluate the clinical efficacy of the extended release formulation of tacrolimus (Advagraf®) in patients with severe atopic dermatitis, who can not be treated adequately with cyclosporine A because of side effects and/or non-responsiveness.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis#912874
- DMT210 Topical Gel in the Treatment of Atopic Dermatitis#1030027
- A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD#1033097
- Dupilumab De-escalation in Pediatric Atopic Dermatitis#835866
- Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis#903746
Record · ID 1138154
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive